Jusko, William J.

General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition

Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics

Pharmacogenetics and Drug MetabolismStatistical Methods in Clinical Trials

Cited by 605

Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies

Cao, Y., Balthasar, J. P., & Jusko, W. J. (2013) · Journal of Pharmacokinetics and Pharmacodynamics

Monoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods

Cited by 161

Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race

Magee, M. H., Blum, R. A., Lates, C. D., & Jusko, W. J. (2001) · The Journal of Clinical Pharmacology

Adrenal Hormones and DisordersPharmacogenetics and Drug Metabolism

Cited by 125

Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients

Bulitta, J. B., Zhao, P., Arnold, R. D., Kessler, D. R., Daifuku, R., Pratt, J., Luciano, G., Hanauske, A.-R., Gelderblom, H., Awada, A., et al. (2009) · Cancer Chemotherapy and Pharmacology

Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery

Cited by 47

Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver

DuBois, D. C., Sukumaran, S., Jusko, W. J., & Almon, R. R. (2013) · Steroids

Estrogen and related hormone effectsAdrenal Hormones and Disorders

Cited by 34

Integrated QSPR–pharmacodynamic model of genomic effects of several corticosteroids

Mager, D. E., Pyszczynski, N. A., & Jusko, W. J. (2003) · Journal of Pharmaceutical Sciences

Computational Drug Discovery MethodsAdrenal Hormones and Disorders

Cited by 19